challenges ahead

18
Prestige Institute of Management, Gwalior Indian Pharmaceutical Industry- Challenges Ahead Presented By- Aditi Bhatnagar Gireesh Sharma Raghuraj Poshwal Shubham Tiwari

Upload: aditi-bhatnagar

Post on 08-Feb-2017

4 views

Category:

Science


0 download

TRANSCRIPT

Page 1: Challenges ahead

Prestige Institute of Management,Gwalior

Indian Pharmaceutical Industry- Challenges Ahead

Presented By-Aditi BhatnagarGireesh Sharma

Raghuraj PoshwalShubham Tiwari

Page 2: Challenges ahead

PHARMACEUTICAL INDUSTRY-

CHALLENGES AHEAD

Page 3: Challenges ahead

INTRODUCTION Rank’s first of India’s Science based Industry Estimated worth $4.5 Billion Organized and Specialized Sector Grown tremendously

Page 4: Challenges ahead

INDIA'S SCENARIO Most Progressive Providing greater employment Attractive Indian Destination Prime destination for - manufacture of branded, - generic, and - branded generic medicines.

Page 5: Challenges ahead

GLOBAL SCENARIO Fastest emerging international centers

Country India’s Pharma ExportUS 27%

Europe 19%

Africa 17%

Middle East 7%

Latin America 6%

CIS Countries 5%

Page 6: Challenges ahead

ThreatLow cost country affecting demand.Counterfeiting threat.Lack of investment in infrastructure.

SWOT ANALYSIS

Page 7: Challenges ahead

CHALLENGES AHEAD

Out of Pocket Expenditure

Make Drug Price Affordable

Counterfeit Medicine

Research and Development

Pricing of Patented Drugs

Page 8: Challenges ahead

OUT OF POCKET EXPENDITURE

Fragile healthcare infrastructure Low penetration of health insurance Poor healthcare delivery system Absence of ‘Universal Health Coverage’

Page 9: Challenges ahead

GOVERNMENT SHARE IN TOTAL HEALTHCARE

COUNTRY BRAZIL CHINA MEXICO SOUTH AFRICA

PAKISTAN

SRI LANKA

INDIA

% of Healthcare Spend

47% 62.5% 49% 44% 33% 45% 29%

Page 10: Challenges ahead

MAKE DRUG PRICE AFFORDABLE

Continuous focus of Government Reasonably Affordable Medicine Critical Challenge

Page 11: Challenges ahead

COUNTERFEIT MEDICINE

India- Capital of Counterfeit Drugs

Fake Medicine Contaminated Illegal Drug

Page 12: Challenges ahead

RESEARCH AND DEVELOPMENT

Page 13: Challenges ahead

PRICING OF PATENTED DRUGS

Page 14: Challenges ahead

TOP 6 PHARMA COMPANY

Indian Pharmacy Market Capitalization (2016)

Sun Pharmaceutical Industry Ltd.

195,257.88 crore INR

Lupin 72,460.78 crore INRDr.Reddy’s Laboratories 52,791.13 crore INRAurobindo Pharma Ltd. 44,528.48 crore INR

Cipla Ltd. 43,141.74 crore INRCadila Healthcare 33,476.38 crore INR

Page 15: Challenges ahead

VISION 2020•Expected to grow over 15%

•Market to grow by US$55 Billion

•80% of Market Share

•Maintain lead over China

Page 16: Challenges ahead

CONCLUSION

Page 17: Challenges ahead

REFERENCEShttp://www.indianmirror.com/indian-industries/pharmaceutical.html

http://www.ibef.org/industry/pharmaceutical-india.aspx

https://pharmanewsprwire.wordpress.com/2012/10/01/nine-major-challenges-constraining-indian-pharmaceutical-industry-from-taking-a-quantum-leap

/

http://www.slideshare.net/rvmfinishingschool/pharma-industry-17272482

http://www.dsir.gov.in/reports/isr1/Pharmaceuticals/7_5.pdf

Page 18: Challenges ahead